Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
The Journal of Rheumatology|October 1, 2022
Reliability of the Pediatric Specific Musculoskeletal Ultrasound Scoring Systems for the Elbow, Wrist, and Finger JointsPatricia Vega-Fernandez, Ysabella Esteban, Edward Oberle, et al.
Contemporary Clinical Trials|February 22, 2021
Randomized clinical trial of Fibromyalgia Integrative Training (FIT teens) for adolescents with juvenile fibromyalgia - Study design and protocolSusmita Kashikar-Zuck, Matthew S Briggs, Sharon Bout-Tabaku, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 31, 2025
Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal TrialHermine I Brunner, Ekaterina Alexeeva, Marcia Bandeira, et al.
Pain|March 19, 2026
Multicenter randomized controlled trial of cognitive-behavioral, exercise-based, and combined interventions for juvenile fibromyalgiaSusmita Kashikar-Zuck, Sara E Williams, Richard F Ittenbach, et al.
The Journal of Rheumatology|November 15, 2025
Evaluation of Health Disparities in Outcomes of Patients With Juvenile Idiopathic ArthritisJulia G Harris, Jade H Singleton, Tracy V Ting, et al.
Contemporary Clinical Trials Communications|December 5, 2022
FIT Teens RCT for juvenile fibromyalgia: Protocol adaptations in response to the COVID 19 pandemicSusmita Kashikar-Zuck, Kimberly A Barnett, Sara E Williams, et al.
Arthritis Care & Research|October 18, 2016
Preliminary Definitions for the Sonographic Features of Synovitis in ChildrenJohannes Roth, Viviana Ravagnani, Marina Backhaus, et al.
Lancet (London, England)|November 12, 2021
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trialNicolino Ruperto, Hermine I Brunner, Olga Synoverska, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of TherapyClaas H Hinze, Dirk Foell, Anne L Johnson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2018
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive DiseaseDaniel J Lovell, Anne L Johnson, Bin Huang, et al.
Pageof 7